[1] Song Shenghu Chen Weiguo Zhao Heng Wang Xiangfu Chen Xiaojuan Chen Caixia,.34 Cases of Postmenopausal Osteoporotic Vertebral Compression Fractures Treated with Calcitriol and Erxian Decoction after PKP [J]. Modern Traditional Chinese Medicine, 2019, (04): 96-99. [doi: 10.13424/j.cnki.mtcm.2019.04.028]
34 Cases of Postmenopausal Osteoporotic Vertebral Compression Fractures Treated with Calcitriol and Erxian Decoction after PKP
- Article number:
- 1672 -0571( 2019) 04 -0096 -04
- ZTFLH:
- R681.5
- Code:
- B
- Abstract:
- To observe the clinical effect of calcitriol combined with Erxian Decoction in the treatment of postmenopausal osteoporotic vertebral compression fracture after percutaneous kyphoplasty ( PKP) . Methods: 68 patients with postmenopausal osteoporotic vertebral compression fracture after PKP were selected and randomly divided into two groups. The control group ( 34 cases) was given orally calcitriol capsule, while the treatment group ( 34 cases) was given orally Erxian Decoction on the basis of taking calcitriol capsule. The clinical effects of the two groups were observed after 12 weeks of treatment. Results: The treatment group was superior to the control group in the visual analogue scale ( VAS) score, the TCM clinical syndrome score, and the bone density. The difference was statistically significant ( P <0. 05) .Conclusion: Postmenopausal osteoporotic vertebral compression fracture treated with calcitriol combined with Erxian decoction after PKP has significant clinical effect in relieving pain symptoms, improving clinical symptoms of traditional Chinese medicine, and improving bone mineral density. It is worthy of promotion.
References:
[1]张玮,王秋萍.绝经后骨质疏松症发病相关危险因素及预防措施研究[J].蚌埠医学院学报,2017,42(11):1506-1509.
[2]林晓生,王海燕,肖庆华,等.717名围绝经期妇女骨量丢失情况的流行病学调查[J].中国骨质疏松杂志,2017,23(3):363-367.
[3]陈效,何飞宇,钟志勇.不同经皮微创治疗方法治疗老年胸腰椎骨质疏松性骨折的疗效比较[J].现代中西医结合杂志,2018,27(7):756-759.
[4]胡永军,李传波,谢娟,等.骨质疏松性骨折后管理现状的调查分析[J].重庆医学,2015,44(21):2970-2972.
[5]李仁波,尚静波,姜丽.PKP治疗骨质疏松性压缩骨折后椎体再骨折的原因分析[J].大连医科大学学报,2018,40(1):43-46.
[6]邱贵兴,裴福兴,胡侦明,等.中国骨质疏松性骨折诊疗指南(骨质疏松性骨折诊断及治疗原则)[J].中华骨与关节外科杂志,2015,8(5):371-374.
[7]夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
[8]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:355-360.
[9]葛继荣,郑洪新,万小明,等.中医药防治原发性骨质疏松症专家共识(2015)[J].中国骨质疏松杂志,2015,21(9):1023-1028.
[10]王想福,陈伟国,叶丙霖.绝经后骨质疏松性椎体压缩骨折的研究进展[J].亚太传统医药,2017,13(23):48-50.
[11]吴琦明,孙基锴,唐文成,等.骨质疏松性胸腰椎椎体压缩性骨折经皮椎体成形术与保守治疗的对比分析[J].中国实用医药,2015,10(36):57-58.
[12]王润民,胡洛爽,沈进稳,等.补肾活血汤治疗骨质疏松性椎体压缩性骨折PKP术后残余疼痛48例[J].陕西中医药大学学报,2017,40(3):48-49+85.
[13]李跃华,颜明辉,吴世伟,等.骨质疏松症患者年龄?中医证型与腰椎压缩性骨折发生关系研究[J].北京中医药,2018,37(03):219-221.
[14]王俊玲.二仙汤治疗骨质疏松的系统评价及用于绝经后骨质疏松治疗的初步研究[D].广州:广州中医药大学,2016.
Memo
收稿日期：２０１８－０５－２７ 编辑：杨芳艳